Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Markers of inflammation, including plasma C-reactive protein (CRP), are associated with an increased risk of cardiovascular disease, and it has been suggested that this association is causal. However, the relationship between inflammation and cardiovascular disease has not been extensively studied i...
Main Authors: | Storey, B, Staplin, N, Haynes, R, Reith, C, Emberson, J, Herrington, W, Wheeler, D, Walker, R, Fellström, B, Wanner, C, Landray, M, Baigent, C |
---|---|
Formato: | Journal article |
Publicado: |
Elsevier
2017
|
Títulos similares
-
Effects of lowering LDL cholesterol on progression of kidney disease.
por: Haynes, R, et al.
Publicado: (2014) -
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
por: Herrington, W, et al.
Publicado: (2014) -
Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
por: Mihaylova, B, et al.
Publicado: (2019) -
Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: Results from the study of heart and renal protection
por: Reith, C, et al.
Publicado: (2017) -
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
por: Cholesterol Treatment Trialists' Collaboration, et al.
Publicado: (2016)